the US Food and Drug Administration has sold the rights to injectables Restylane , Perlane , Emervel, Nestlé and Dysport to Galderma for $ 1.4bn . The sale was previously agreed with Sculptra , which recently acquired Galderma . Beginning July 28, Galderma will have a new branded distribution process. Emervel Classic and Emervel Deep are currently awaiting approval from Valeant Pharmaceuticals and the US Food and Drug Administration .
the US Food and Drug Administration has sold the rights to injectables Restylane , Perlane , Emervel, Nestlé and Dysport to Galderma for $ 1.4bn . The sale was previously agreed with Sculptra , which recently acquired Galderma . Emervel Classic and Emervel Deep are currently awaiting approval from Valeant Pharmaceuticals and the US Food and Drug Administration .